Publicly listed CRISPR biotech companies

End to end pipeline to generate movies using AI

Introduction to a Generic C Library

Someone collected tens of thousands in pandemic unemployment benefits in my name

What incentivizes banks to offer API access?

Hi all - I'm curious.. what's incentivizes banks to offer API access to their customers data?They are enabling a whole generation of fintech companies to make a fortune, but what's in it for the banks?Do fintech companies have to pay the banks a fee for each api call?Thanks for your insight.

Thinking on Paper – a collection of building blocks

The following building blocks for thinking on paper could be used on their own, but their combination seems much stronger to me.Building block 1: Use a sheet layout with smallish boxes, a) to form manageable "units of thinking" that can be concatenated box by box and step by step, and b) to trigger frequent refocusings on the most relevant aspects in the process of thinking.Building block 2: Use thinking tools to generate content in those boxes, with tools for reflection being especially useful.Building block 3: For the boxes, choose from a variety of note-taking elements, notably mind maps.Building block 4: Work persistently over a series of sheets.Here's an illustration: https://tinyurl.com/yt3zp4m3

Detect Faces Generated by Thispersondoesnotexist.co

Ask HN: Does anyone here have a “co-mentor?”

You hear a lot about the benefits of having a mentor but I’ve never had success finding and keeping a mentor. I now have two “co-mentors” and it’s been incredibly beneficial. With a co-mentor, you’re both offering value to each other and this helps to maintain the relationship over time. Do you have a co-mentor? I’d love to hear about any similar experiences and also happy to answer any questions about how my co-mentor setup is organized.

Hadmean: Introducing the easiest, most efficient internal tool generator

FakeClients UI – UI – Generate Briefs, Prompts and Exercises to Practice

Post your work in a profile that will benefit you even after months

Show HN: I made a Web3 app that lets you create a crypto money pot

Hey!I made a web3 app that lets you create a crypto money pot to finance anything you want: the aim is to provide a simple way to create pots on the blockchain for all kind of projects, association, or other stuffs …With Cryptopots, you just create a pot in a few clicks, with the assets you want, on the blockchain you want, for anything you want! Most of the money pots services take some important fees (2%-4% for small pots). We’re planning to make a much cheaper service to permit the owner to make the most benefits possible.We’re actually in private beta, but get your access to try it now!Just a decentralized, uncensorable, and community oriented way to create your pots.Let’s make the web great again!What do you think about our landing page and our idea ?

If We Live in a Sick World, We Get Sick. What Happens if We Choose Refuge Over Righteousness?

For ourselves. For others.

ビル・ゲイツの財団が赤血球の病気を遺伝子編集技術「CRISPR」で治療するスタートアップに資金を援助 - GIGAZINE https://t.co/T1OVkwPu9A

ビル・ゲイツ氏と妻のメリンダ・ゲイツ氏によって創設されたビル＆メリンダ・ゲイツ財団が、遺伝子編集技術の「CRISPR/Cas9」を用いて遺伝性の貧血病である鎌状赤血球症の治療を目指すスタートアップ・Intellia Therape… https://t.co/RwtI7nfTXN

ビル・ゲイツ氏と妻のメリンダ・ゲイツ氏によって創設されたビル＆メリンダ・ゲイツ財団が、遺伝子編集技術の「CRISPR/Cas9」を用いて遺伝性の貧血病である鎌状赤血球症の治療を目指すスタートアップ・Intellia Therape… https://t.co/RwtI7nfTXN

Beam Therapeutics Inc., BEAM: Daily Chart, September 30 2022 Moving as expected, looking for at least one more leg… https://t.co/mlLujNDfOe

[email protected] of @broadinstitute & @Harvard co-founded Prime. Liu has co-founded several #geneediting companies inclu… https://t.co/BEvc9Le9JB

New Report: Digital Reset. Redirecting Technologies for the Deep Sustainability Transformation. The report "Digita… https://t.co/o1iwjFSd61

Kidney Patients Remind Congress and Payers: Your Decisions Impact Our Lives and Innovation

Largest Kidney Patient Meeting Shows Patient Determination for ChangeWASHINGTON, Sept. 29, 2022 /PRNewswire/ -- The American ...

CRISPR/CAS 9 Technology Market Size Worth USD 6,221 Million in 2028

The key players profiled in the report are Boston Merck KGaA, AstraZeneca PLC, GenScript, eGenesis, Caribou Biosciences, Inc., Horizon Discovery Group plc, Lonza, Thermo Fisher Scientific, Inc., Hera ...

Build for the future now with Mammoth Biosciences and Mayfield

Trevor Martin’s Mammoth Biosciences aims to use CRISPR technology to democratize disease detection. Join this TechCrunch Live ...